Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia

Pathobiology

Volumn 81, Issue 1, 2013, Pages 42-52

  Johansen, Flemming F ^a   Hasseldam, Henrik ^a   Rasmussen, Rune S ^a   Bisgaard, Anne Sofie ^a   Bonfils, Peter K ^a   Poulsen, Steen S ^a   Hansen Schwartz, Jacob ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KØGE HOSPITAL   (Denmark)

Author keywords

Cell density; Endothelial cells; Growth factor; Hypoxia ischemia; Necrosis; Pathogenesis; Pathology

Indexed keywords

SODIUM CHLORIDE; TALIPEXOLE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN DAMAGE; BRAIN HOMOGENATE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORE TEMPERATURE; CRANIAL WINDOW TEMPERATURE; FEASIBILITY STUDY; HYPOTHERMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECTUM TEMPERATURE; STEREOLOGY; WESTERN BLOTTING; BODY TEMPERATURE MONITORING; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG INFUSION; EXPERIMENTAL STROKE; HISTOPATHOLOGY; HYPOTENSION; INDUCED HYPOTHERMIA; NEUROPROTECTION; SURVIVAL RATE;

ANIMALS; AZEPINES; BLOTTING, WESTERN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; HYPOTHERMIA, INDUCED; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS;

EID: 84887108996     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000352026     Document Type: Article

References (51)

1. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
2. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA, Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators: Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344: 395-403.
3. Kirino T: Ischemic tolerance. J Stroke Cerebrovasc Dis 2002; 22: 1283-1296. (Pubitemid 35285085)
4. Nishio S, Masatoshi Y, Zong-Fu C, Anzivino MJ, Lee KS: Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J Neurosurg 2003; 93: 845-851.
5. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW: 1,026 experimental treatments in acute stroke. Ann Neurol 2006; 59: 467-477. (Pubitemid 43358067)
6. Liu L, Yenari MA: Therapeutic hypothermia: neuroprotective mechanisms. Front Biosci 2007; 12: 816-825. (Pubitemid 46846858)
7. Yunoki M, Nishio S, Ukita N, Anzivino MJ, Lee KS: Characteristics of hypothermic preconditioning influencing the induction of delayed ischemic tolerance. J Neurosurg 2002; 97: 650-657. (Pubitemid 34994383)
8. Yunoki M, Nishio S, Ukita N, Anzivino MJ, Lee KS: Hypothermic preconditioning induces rapid tolerance to focal ischemic injury in the rat. Exp Neurol 2003; 181: 291-300. (Pubitemid 36629249)
9. Kammersgaard LP, Jorgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J, Olsen TS: Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke 2002; 33: 1759-1762. (Pubitemid 34761056)
10. Wang Y, Lim LL, Levi C, Heller RF, Fisher J: Influence of admission body temperature on stroke mortality. Stroke 2000; 31: 404-409. (Pubitemid 30078173)
11. Hemmen TM, Lyden PD: Induced hypothermia for acute stroke. Stroke 2007; 38: 794-799. (Pubitemid 46184261)
12. van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR: Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 2007; 130: 3063-3074. (Pubitemid 350209058)
13. Johansen FF, Jorgensen HS, Reith J: Prolonged drug-induced hypothermia in experimental stroke. J Stroke Cerebrovasc Dis 2003; 12: 97-102. (Pubitemid 36506250)
14. Bonfils PK, Reith J, Hasseldam H, Johansen FF: Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia. Neurochem Int 2006; 49: 508-518. (Pubitemid 44189647)
15. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR: A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10: 290-293. (Pubitemid 20096202)
16. Nijsen MJ, Ongenae NG, Coulie B, Meulemans AL: Telemetric animal model to evaluate visceral pain in the freely moving rat. Pain 2003; 105: 115-123. (Pubitemid 37162480)
17. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB: Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 2002; 22: 6401-6407. (Pubitemid 35386396)
18. Fang J, Chen L, Fan L, Wu L, Chen X, Li W, Lin Y, Wang W: Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats. J Mol Cell Cardiol 2011; 51: 839-847.
19. Zhao H: The protective effects of ischemic postconditioning against stroke: from rapid to delayed and remote postconditioning. Open Drug Discov J 2011; 5: 138-147.
20. Pabello NG, Tracy SJ, Snyder-Keller A, Keller RW Jr: Regional expression of constitutive and inducible transcription factors following transient focal ischemia in the neonatal rat: influence of hypothermia. Brain Res 2005; 1038: 11-21. (Pubitemid 40340956)
21. Ohta H, Terao Y, Shintani Y, Kiyota Y: Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the neuroprotection in rat focal cerebral ischemia. Neurosci Res 2007; 57: 424-433. (Pubitemid 46283078)
22. Dietrich WD, Busto R, Alonso O, Globus MY-T, Ginsberg MD: Intra-ischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 1993; 13: 541-549. (Pubitemid 23187496)
23. Durukan A, Tatlisumak T: Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87: 179-197. (Pubitemid 46860315)
24. Gerriets T, Stolz E, Walberer M, Kaps M, Bachmann G, Fisher M: Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance. Stroke 2003; 34: 2234-2239. (Pubitemid 37099842)
25. Li F, Omae T, Fisher M: Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats. Stroke 1999; 30: 2464-2470.
26. Popp A, Jaenisch N, Witte OW, Frahm C: Identification of ischemic regions in a rat model of stroke. PLoS ONE 2009; 4:e4764.
27. Nishio S, Chen ZF, Yunoki M, Toyoda T, Anzivino M, Lee KS: Hypothermia-induced ischemic tolerance. Ann NY Acad Sci 1999; 890: 26-41. (Pubitemid 30040362)
28. Kato H, Liu Y, Araki T, Kogure K: Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res 1991; 553: 238-242.
29. Kirino T, Tsujita Y, Tamura A: Induced tolerance to ischemia in gerbil hippocampal neurons. J Cereb Blood Flow Metab 1991; 11: 299- 307.
30. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, Kamada T: 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res 1991; 561: 203-211.
31. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: 579-588.
32. Clark WG, Clark YL: Changes in body temperature after administration of antipyretics, LSD, Ag-TCH, CNS depressants and stimulants, hormones, inorganic ions, gases, 2,4- DNP and miscellaneous agents. Neurosci Biobehav Res 1981; 5: 1-136. (Pubitemid 11073157)
33. Cox B, Lee TF: Evidence for an endogenous dopamine-mediated hypothermia in the rat. Br J Pharmacol 1979; 67: 605-610. (Pubitemid 10164532)
34. Nava F, Carta G, Gessa GL: Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats. Pharmacol Biochem Behav 2000; 66: 183- 187. (Pubitemid 30317533)
35. Salmi P, Jimenez P, Ahlenius S: Evidence for specific involvement of dopamine D 1 and D 2 receptors in the regulation of body temperature in the rat. Eur J Pharmacol 1993; 236: 395-400. (Pubitemid 23170380)
36. Salmi P: Independent roles of dopamine D 1 and D 2/3 receptors in rat thermoregulation. Brain Res 1998; 781: 188-193. (Pubitemid 28082861)
37. Sanchez C, Amt J: Effects on body temperature in mice differentiate between dopamine D 2 receptor agonists with high and low efficacies. Eur J Pharmacol 1992; 211: 9-14.
38. Anden NE, Golembiowska-Nikiten K, Thomstrom U: Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunun Schmiedebergs Arch Pharmacol 1982; 32: 100-104. (Pubitemid 13238876)
39. Nobuyoshi Kodani, Boehringer Ingelheim, personal communication, 2000.
40. Knoll T, Wimmer ML, Gumpinger F, Haberl RL: The low normothermia concept - maintaining a core body temperature between 36 and 37 degrees C in acute stroke unit patients. J Neurosurg Anesthesiol 2002; 14: 304-308.
41. The Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurological outcome after cardiac arrest. N Engl J Med 2002; 346: 549-556.
42. Hsu WH, Schaffer DD, Dyer DC: The emetic effect of B-HT 920 and apomorphine in the dog: antagonism by haloperidol. Life Sci 1986; 39: 1021-1026. (Pubitemid 16033114)
43. Cummings JL: Neuropsychiatric complications of drug treatment in Parkinson's disease; in Huber S, Cummings JL (eds): Parkinson's Disease: Neurobehavioral Aspects. New York, Oxford University Press, 1992, pp 313- 327.
44. Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, Simon ES, Korczyn AD: Risk factors for dementia, depression, and psychosis in long-standing Parkinson's disease. J Neural Transm 2000; 10: 759-771.
45. Aarsland D, Larsen JP, Cummings JL, Laake K: Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community- based study. Arch Neurol 1999; 56: 595-601. (Pubitemid 29218155)
46. Wallace TL, Gudelsky GA, Vorhees CV: Methamphetamine-induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. J Neurosci 1999; 19: 9141-9148. (Pubitemid 30226734)
47. Rasmussen RS, Overgaard K, Hildebrandt- Eriksen ES, Boysen G: D -amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model. Acta Neurol Scand 2006; 113: 189-198.
48. Bozzi Y, Borrelli E: Dopamine in neurotoxicity and neuroprotection: what do D 2 receptors have to do with it? Trends Neurosci 2006; 29: 167-174.
49. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Kimura J, Shimohama S: Dopamine D 2 -type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress. Ann Neurol 1998; 44: 110-119. (Pubitemid 28323660)
50. Ukai W, Ozawa H, Tateno M, Hashimoto E, Saito T: Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol. J Neural Transm 2004; 111: 667-681. (Pubitemid 38716547)
51. Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata- Ichikawa E, Ogawa N: Dopamine D 2 receptor- mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res 1999; 838: 51-59. (Pubitemid 29389818)